Team

Marta Barrachina

CEO
CO-FOUNDER

PhD in Biochemistry (University of Barcelona) and Executive MBA (La Salle – Ramon Llull University).

Specialist in gene regulation and epigenetics in neurodegenerative and neurological diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and Schizophrenia. Author of 36 scientific articles published in international journals related to neurosciences, h index equal to 22, and inventor of 7 patents. Miguel Servet researcher (Institute of Health Carlos III - ISCIII) in 2008 but she declined it by a permanent position in IDIBELL as principal investigator. She has leaded several national and private competitive projects in the last twelve years (Institute of Neuropathology – Bellvitge Hospital – IDIBELL). She has directed two doctoral thesis and five experimental masters.

Ramón Reñé

MEDICAL ADVISORY BOARD
CO-FOUNDER

MD, PhD in Medicine and Surgery
(Autonomous University of Barcelona)

Head of Functional Dementia Unit in Bellvitge University Hospital. He has large experience in the treatment of patients with Mild Cognitive Impairment, Vascular Dementia, Frontotemporal Degeneration and Dementia with Lewy Bodies. He has leaded more than ten clinical trials in the last five years in collaboration with pharmaceutical companies (GSK, Sanofi, Noscira, Servier, Grifols, Lundbeck, Astra Zeneca, Eli Lilly, Biogen and Roche). Moreover, he has also been focused on caregivers, maintaining a tight vinculation with Alzheimer’s familiar Associations.

Jordi Gascón

Medical Advisory Board
CO-FOUNDER

MD in Medicine and Surgery
(Autonomous University of Barcelona)

Neurologist specialist in Dementia and Neurometabolic diseases in the Functional Dementia Unit of Bellvitge University Hospital. Associate professor in Morphological Sciences in Autonomous University of Barcelona. Expert in the management and treatment of Mild cognitive impairment and Dementias: Alzheimer’s disease, Dementia with Lewy Bodies, Frontotemporal Dementia and Amyotrophic lateral Sclerosis with cognitive or behavioural impairment. He is a reference neurologist for the treatment of Niemann-Pick C in the adult. Large experience in clinical trials with pharmaceutical companies in the last ten years and as a consultant at his hospital.

Inma Valle

Business Development Advisor

She holds a PhD in Biochemistry & Molecular Biology from University Autonoma of Madrid, and a Master in Biotechnology Management with a focus on healthcare from IE Business School. She spent 4 years working as a researcher at the Diabetes Center at UCSF, where she focused on central regulation of metabolic disorders (obesity, type 2 diabetes, and so on).

Biologist by training, Life Sciences entrepreneur & investment professional. Passionate about the biotechnology field, specially focused on early stage health care companies. Inma cofounded Metabostem, a biotech company focused on development of new therapies targeting cancer stem cells, where she holds the CEO position. Additionally, Inma collaborates as mentor and teacher with different programs to help develop new companies in the bio-health sector (CaixaImpulse, Bioemprendedor XXI, dHEALTH).
Previously, she was Investment Manager at Caixa Capital Risc, venture arm of La Caixa, where she lead +10 investments in the Life Sciences Sector and sat as Board Member at 4 biotechnology companies.

Josep Lluís Falcó

Regulatory and Business Strategy Advisor

Doctor in Chemistry (Institut Químic de Sarrià) and MBA (Universitat de Barcelona).

Josep Lluís has 21 years of experience in the biomedical sector. He has worked for big pharma companies (Sanofi), mid-size pharmas (Ferrer Grupo), small biotechs (Hospital spin-off), Tech Transfer Offices (Fundació Bosch i Gimpera) and Consulting firms (Antares Consulting and Asphalion). He has also been associate professor at IQS. His experience is based in Healthcare Strategy, Technology Transfer, Fundraising of start-up companies, Business Development, Marketing, Market Access, Reimbursement and Regulatory Affairs. Josep Lluís has founded 4 companies. He currently serves as board member for 3 start-up companies and he is mentor of several entrepreneurs. In addition in the last 5 years he has been involved in 11 private fundraising processes and he has contributed to raise 40 million euros for his clients. The projects in which Josep Lluís has been involved are based in small chemical entities, biologicals, diverse medical devices, in vitro diagnostics, nutraceuticals and cosmetics. The therapeutic areas where he has recently worked are Oncology, Central Nervous System, Cardiovascular, Ophthalmology, Orthopedics, Traumatology, HIV, Microbiome, Antibacterials and Immunomodulation. He has global knowledge of drug/device development, having worked in Discovery, Preclinical and Clinical phases, Marketing and Post-Marketing. He takes part of programs such as Caixa Impulse and EIT Health programs, participating as reviewer, mentor and professor. The entrepreneurial spirit runs through his veins. He has founded GENESIS Biomed to help other entrepreneurs and research centers in their current projects.